America has long taken a free market approach to pharmaceuticals.
Drug companies haggle separately over drug prices with a variety of private insurers across the country...
https://t.co/1I9JlE5Ysa
LONG COVID\u201430% of hospital recovered #COVID19 patients end up back in hospital in <5 months; up to 12% die of complications. \u201cwe really need to prepare for #LongCovid. It\u2019s a mammoth task to follow up w/ these patients, but monitoring needs to be arranged\u201dhttps://t.co/h0y8WUn8sQ pic.twitter.com/Pk8GhQc9J5
— Eric Feigl-Ding (@DrEricDing) January 18, 2021
Immunocompromised 45 year old suffered from #COVID19 for 155 days before he died. The virus was changing very quickly inside the man's body\u2014it acquired a big cluster of >20 mutations\u2014resembled the same ones seen in #B117 & #B1351. (NPR audio Part 1 of 2)\U0001f9f5https://t.co/7kWiBZ1xGk pic.twitter.com/ZJ7AExB78Y
— Eric Feigl-Ding (@DrEricDing) February 8, 2021
2) NPR report audio part 2 of 2:
— Eric Feigl-Ding (@DrEricDing) February 8, 2021
Dr. Li couldn't believe what they found. "I was shocked," he says. "When I saw the virus sequences, I knew that we were dealing with something completely different and potentially very important." pic.twitter.com/HT3Yt6djFd
HHS @SecBecerra has tested positive for COVID-19 again, the agency just announced. Last time he tested positive was May 18, after attending the G-7 Summit.
— Ariel Cohen (@ArielCohen37) June 13, 2022
\U0001f4c8Surging #BA5 & #BA4 variants in both US & England. It\u2019s looking like #Ba5 is the new fastest strain\u2014which has ~10x increased in England in 1 month. Also notice that older #Omicron #B11529/#BA1 are already near *extinct*. I worry the \u201cnew\u201d Omicron BA1 bivalent vaccine is behind. pic.twitter.com/kLNH0gzPk3
— Eric Feigl-Ding (@DrEricDing) June 9, 2022
To anyone pointing to South Africa to suggest the impact of the omicron wave has been 'mild' or that the BA.4/5 haven't had much impact, I'd urge you to look at excess deaths. 29,500 excess deaths since Jan (omicron wave) & a peak of 1,844 excess deaths/wk during BA.4/5 wave.\U0001f9f5 pic.twitter.com/r7kLzmD5dG
— Dr. Deepti Gurdasani (@dgurdasani1) June 11, 2022
4) Look at these 97 Paxlovid patients here with viral RNA load data over time. Of 97, i conservatively counted at least 12 of 97 (12%) with viral load rebound after day 10. Even more if you count rebound after day 5. Thus, FDA\u2019s 1-2% doesn\u2019t match up here. https://t.co/bNoqj5W3Sk pic.twitter.com/B3Kh0Lc1A4
— Eric Feigl-Ding (@DrEricDing) May 5, 2022
Unfortunately neutralization experiments found that BA.4/5 is 2x more resistant than BA.2 to the blood obtained from vaccinated individuals who had a breakthrough infection with BA.1 or BA.2. 4/ pic.twitter.com/MEOPXuqTgg
— Dr. Jeff Gilchrist (@jeffgilchrist) June 13, 2022
\u26a0\ufe0fAIRBORNE >6 FEET / 2 METERS! The CDC finally acknowledged #SARSCoV2 has major transmission via airborne aerosols beyond 6 feet / 2 meters, not just close contact. The CDC/WHO & airborne deniers are a year late\u2014and negligently endangered many. #COVID19 \U0001f9f5https://t.co/1YMqDGbD0v pic.twitter.com/DUm5FA3V90
— Eric Feigl-Ding (@DrEricDing) May 8, 2021
Now, in the short-term, the manufacturing sector is red hot, driven by a pent-up demand rebound in goods consumption.
— Eric Basmajian (@EPBResearch) January 4, 2021
Commodity prices are screaming which gives legs to "goods" inflation in the short-term.
8) pic.twitter.com/rQcqHf1OD0
Consensus continues to conflate the inflation story, mixing and matching long-term and short-term charts to fit what is generally a secular inflation narrative.
— Eric Basmajian (@EPBResearch) January 4, 2021
Here are my two cents to make the distinction clear.
1)